The Official Newspaper of the University of Leeds since 1897

The Official Newspaper of the University of Leeds. Writing inspiring and meaningful stories since 1897

Immunotherapy: Supercharging the Immune System to Fight Cancer

0

In recent years, a new approach to treating cancer has emerged: immunotherapy.

s3

Cancer is one of the leading causes of death worldwide, accounting for approximately 10 million deaths in 2020. Whilst traditional cancer treatments, such as chemotherapy and radiation therapy, have paved the way as the most effective treatments for cancer, in recent years, a new approach to treating cancer has emerged: immunotherapy.

Traditional cancer treatments include chemotherapy and radiation therapy. However, In recent years, a new approach to treating cancer has emerged: immunotherapy. Image: Flickr

The immune system is designed to detect and destroy abnormal cells, which prevents the growth of many cancers. However, in some cases, cancer cells will evolve ways to avoid detection by the immune system and avoid being destroyed. The goal of immunotherapy is to boost the ability of the immune system to recognise and attack such cancer cells.

The concept of using the immune system to treat cancer has its beginnings in 1981, when William Coley (who is widely recognised as one of the founding fathers of cancer immunotherapy), attempted to harness the power of the immune system for treating cancer. His studies involved injecting bacteria into patient tumours with the hope of triggering an immune response to the infection that would also attack the tumour. Coley achieved some remarkable results, with tumour regression seen in several patients. Despite this, the risks associated with deliberately infecting patients with bacteria meant that surgery and radiotherapy were accepted as the standard treatments for cancer in the 20th century. However, in recent years, immunotherapy has been revolutionised by several advances, particularly with the development of CAR-T cell therapies.

A cartoon showing a T cell fighting a cancer cell. Image: Alessia Stanistreet-Welsh

CAR-T cell therapy involves the removal of immune cells (T cells) from a patient’s blood, genetically engineering them to recognise and attack cancer cells, then infusing the modified cells back into the patient’s blood. The biggest advantage of this treatment is that it is personalised to each patient, as the therapy is tailored to target the unique genetic mutations and characteristics of the patient’s cancer.

CAR-T therapy has produced considerable success in clinical trials for several types of blood cancers. For example, CAR-T cell therapy has produced response rates of up to 90% in patients with relapsed or refractory B-cell lymphomas, which is significantly higher than conventional treatments. Such positive clinical trials have led to the approval of certain immunotherapies for treatment, with the FDA approving CAR-T cell therapy to treat a form of leukaemia in 2017.

Despite this, immunotherapy is still relatively new, meaning that more research is needed to determine its effectiveness for a wide range of cancers and to fully understand its potential side effects. Furthermore, immunotherapy itself still only remains an option for treatment after all other options have been exhausted.

Despite its limitations, immunotherapy is likely to become a staple in the clinician’s toolbox for treating cancer. Crystal Mackall is a researcher at Stanford University, hoping to develop CAR-T cell therapy to treat brain tumours. In a report to Nature, she recognised that immunotherapy still presents considerable challenges, stating “we clearly have a long way to go”. Despite this, Mackall has hope for the future of immunotherapy, predicting that immunotherapy will “go way beyond cancer in the years to come”, suggesting that it may become a treatment for a wide range of conditions.

Leave a Reply

Your email address will not be published. Required fields are marked *

Weather

High: 13°C

Low: 8°C

Rain: 78%

Sunset: 08:07 PM

As an independent media outlet, we hold the University and the Union to account where possible. We provide a range of content that is of interest to students and residents of Leeds.

×

Write for Us

We are always looking for talented writers to contribute to the Gryphon! If you have a passion for newspapers (or writting in general), we encourage you to submit your work. Please review the following guidelines before submitting your article:

Original Content: We only accept original articles that have not been previously published elsewhere.
Writing Style: Use a clear and concise writing style, and ensure your article is well-structured and easy to read.
Images: If you include images, please ensure you have the necessary rights to use them. Provide appropriate attribution.

We will review your submission and notify you. If your article is selected for publication. We reserve the right to edit articles for clarity and style.

×

Advertise With Us

Looking to connect with engaged readers? The Gryphon offers a unique platform to showcase your brand and reach a Student population.

Why Advertise with Us?

Targeted Reach: Connect with a specific demographic interested in Local news, arts & culture and student life.

High Engagement: Our readers are actively involved and value the content we provide.
Multiple Opportunities: We offer a range of advertising options to suit your needs and budget, including banner ads and sponsored content.

Interested in learning more?
Contact us at editor@thegryphon.co.uk to discuss advertising opportunities and rates. We look forward to partnering with you!

Contact Us

editor@thegryphon.co.uk


Issues with website?